Junior Resident, Institute of Respiratory Diseases, SMS Medical College, Jaipur, Rajasthan, India.
Assistant Professor, Shija Academy of Health Sciences, Imphal, Manipur, India.
J Assoc Physicians India. 2024 Oct;72(10):50-52. doi: 10.59556/japi.72.0666.
In patients with chronic obstructive pulmonary disease (COPD), early detection of noninvasive ventilation (NIV) failure is a promising technique for decreasing mortality. The objective of this study was to evaluate the efficacy of heart rate, acidosis, consciousness, oxygenation, and respiratory rate (HACOR) score in predicting NIV outcome in COPD-associated respiratory failure.
A prospective observational study was conducted on 100 COPD patients with acute respiratory failure who were initiated on NIV. HACOR score was calculated at the start of NIV and after 1-2, 12, and 24 hours. NIV failure was defined as progression to invasive mechanical ventilation or death. NIV success was defined as liberation from NIV prior to hospital day seven and not meeting criteria for failure.
In this study, 100 patients with COPD and respiratory failure were enrolled. Their mean age was 65.34 years [standard deviation (SD) 8.19]. Male patients were predominant ( = 81). Eighty-nine percent of patients were smokers, and the remaining had exposure to biomass fuel. At the initiation of NIV, the median HACOR score was 3 (interquartile: 2, 4). In 13% of patients, there was NIV failure. There were 17 (17%) patients whose HACOR score at initiation was ≥5. In patients with a HACOR score ≥5, the NIV failure rate was 76.4% and mortality was 41.1%. The area under the curve (AUC) for prediction of NIV failure by HACOR score at initiation was 0.980 (-value < 0.05).
The HACOR score had high sensitivity as well as specificity at initiation in the prediction of NIV failure. A higher HACOR score predicts a high chance of NIV failure. Obtaining the HACOR score at the bedside makes it convenient for assessing the efficacy of NIV in patients with COPD.
在慢性阻塞性肺疾病(COPD)患者中,早期发现无创通气(NIV)失败是降低死亡率的一种有前途的技术。本研究的目的是评估心率、酸中毒、意识、氧合和呼吸频率(HACOR)评分在预测 COPD 相关呼吸衰竭患者 NIV 结局中的疗效。
对 100 例急性呼吸衰竭接受 NIV 治疗的 COPD 患者进行前瞻性观察研究。在开始 NIV 时以及 1-2、12 和 24 小时后计算 HACOR 评分。NIV 失败定义为进展为有创机械通气或死亡。NIV 成功定义为在入院后 7 天前从 NIV 中解放出来且不符合失败标准。
本研究纳入 100 例 COPD 合并呼吸衰竭患者。他们的平均年龄为 65.34 岁(标准差 8.19)。男性患者居多(=81)。89%的患者为吸烟者,其余患者有接触生物燃料的情况。在开始 NIV 时,HACOR 评分中位数为 3(四分位距:2,4)。在 13%的患者中出现了 NIV 失败。有 17(17%)例患者的 HACOR 评分在开始时≥5。在 HACOR 评分≥5 的患者中,NIV 失败率为 76.4%,死亡率为 41.1%。HACOR 评分对 NIV 失败的预测的曲线下面积(AUC)为 0.980(<0.05)。
HACOR 评分在预测 NIV 失败时具有较高的敏感性和特异性。较高的 HACOR 评分预示着 NIV 失败的可能性较高。在床边获得 HACOR 评分可方便评估 COPD 患者 NIV 的疗效。